Illinois Municipal Retirement Fund Has $11.09 Million Holdings in Kenvue Inc. $KVUE

Illinois Municipal Retirement Fund raised its holdings in Kenvue Inc. (NYSE:KVUE) by 12.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 643,141 shares of the company’s stock after acquiring an additional 72,348 shares during the period. Illinois Municipal Retirement Fund’s holdings in Kenvue were worth $11,088,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Elyxium Wealth LLC bought a new position in shares of Kenvue in the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. grew its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after purchasing an additional 618 shares during the last quarter. MV Capital Management Inc. bought a new stake in shares of Kenvue during the 4th quarter valued at approximately $28,000. Reflection Asset Management acquired a new position in Kenvue during the 4th quarter worth approximately $32,000. Finally, SBI Securities Co. Ltd. increased its position in Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after purchasing an additional 1,027 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several research reports. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Barclays decreased their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. UBS Group upped their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday. Citigroup dropped their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Finally, Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $19.50.

Kenvue Stock Performance

Kenvue stock opened at $19.03 on Friday. The business has a 50 day moving average of $18.17 and a 200-day moving average of $17.85. The company has a market capitalization of $36.55 billion, a P/E ratio of 22.39, a P/E/G ratio of 1.42 and a beta of 0.47. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same period last year, the company earned $0.24 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. On average, equities research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.59% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.